alexa Denong Wang | SRI International Biosciences Division
ISSN: 0974-276X

Journal of Proteomics & Bioinformatics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Denong Wang

Denong Wang Denong Wang
Senior Program Director-Tumor Glycome Laboratory
Center for Cancer Research
SRI International Biosciences Division
USA
Tel. 650-859-2789 (O)
Biography

Denong Wang, Ph.D., is an SRI distinguished scientist and senior program director of the Tumor Glycome Laboratory in the Center for Cancer and Metabolism in SRI Biosciences. Wang’s long-term research interest is in the carbohydrate moieties that are critical for self/non-self recognition and induction of antibody responses. Wang’s team has established multiple platforms of carbohydrate microarrays and introduced these glycomics tools to explore the structural and antigenic diversities of the glycome. The main research focus of his lab is in the immunogenic sugar moieties. In the past few years, his group has contributed to the identification of immunologically potent glycan markers of SARS-CoV, Bacillus anthracis exosporium, and a number of human cancers. Wang received his Ph.D. in immunology and glycobiology with the late Professor Elvin A. Kabat at Columbia University in 1993. After that, he entered the developing field of post-genomics research. Before joining SRI in 2010, he served as head of the Functional Genomics Division at Columbia University’s Genome Center from 1998 to 2003 and was director of Stanford University’s Tumor Glycome Laboratory from 2007 to 2010.

Research Interest

Wangs long-term research interest is in the immunogenic sugar moieties that play key roles in the host recognition of complex carbohydrates and immune responses to carbohydrate antigens.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Unraveling Sugar Chain Signatures of the “Seeds” of Tumor Metastasis
Denong Wang
Editorial: J Proteomics Bioinform Vol.10: e31
DOI: 10.4172/jpb.1000e31
 
Glyco-epitope Diversity: An Evolving Area of Glycomics Research and Biomarker Discovery
Denong Wang
Editorial: J Proteomics Bioinform Vol.7.2 e24
DOI: 10.4172/jpb.10000e24
 
The 10th Anniversary of Carbohydrate Microarrays (2002-2012)
Denong Wang and Nathan Collins
Editorial: J Proteomics Bioinform/ Vol.6.2 (2013)
DOI: 10.4172/jpb.10000e22
 
N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients
Denong Wang
Research Article: JPB / Vol.5.4 090-095 (2012)
DOI: 10.4172/jpb.1000218
 
Insights of New Tools In Glycomics Research
Denong Wang, Srinubabu Gedela
Editorial: J Proteomics Bioinform Vol.1.8 374-378(2008)
DOI: 10.4172/jpb.1000046
 

Journal of Proteomics & Bioinformatics - A Research Strategy Established in Glycosciences


A Research Strategy Established in Glycosciences

Presented by: Denong Wang
Senior Program Director-Tumor Glycome Laboratory
SRI International Biosciences Division
USA

Denong Wang, Ph.D., is an SRI distinguished scientist and senior program director of the Tumor Glycome Laboratory in the Center for Cancer and Metabolism in SRI Biosciences. Wang’s long-term research interest is in the carbohydrate moieties that are critical for self/non-self recognition and induction of antibody responses. Wang’s team has established multiple platforms of carbohydrate microarrays and introduced these glycomics tools to explore the structural and antigenic diversities of the glycome. The main research focus of his lab is in the immunogenic sugar moieties. In the past few years, his group has contributed to the identification of immunologically potent glycan markers of SARS-CoV, Bacillus anthracis exosporium, and a number of human cancers. Wang received his Ph.D. in immunology and glycobiology with the late Professor Elvin A. Kabat at Columbia University in 1993. After that, he entered the developing field of post-genomics research. Before joining SRI in 2010, he served as head of the Functional Genomics Division at Columbia University’s Genome Center from 1998 to 2003 and was director of Stanford University’s Tumor Glycome Laboratory from 2007 to 2010.

 
Download PPT PPT Views: 201 Updated on: 2015-10-19 For Recent Update: Click here
 
 
Download PDF   PDF Views: 201  Updated on: 2015-10-19 For Recent Update: Click here
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords